287 related articles for article (PubMed ID: 18006146)
21. Chalcone inhibits the proliferation of human breast cancer cell by blocking cell cycle progression and inducing apoptosis.
Hsu YL; Kuo PL; Tzeng WS; Lin CC
Food Chem Toxicol; 2006 May; 44(5):704-13. PubMed ID: 16307839
[TBL] [Abstract][Full Text] [Related]
22. Histone deacetylase inhibitor valproic acid inhibits proliferation and induces apoptosis in KM3 cells via downregulating VEGF receptor.
Dong XF; Song Q; Li LZ; Zhao CL; Wang LQ
Neuro Endocrinol Lett; 2007 Dec; 28(6):775-80. PubMed ID: 18063935
[TBL] [Abstract][Full Text] [Related]
23. Effects of the histone deacetylase inhibitor valproic acid on the sensitivity of anaplastic thyroid cancer cell lines to imatinib.
Catalano MG; Pugliese M; Poli R; Bosco O; Bertieri R; Fortunati N; Boccuzzi G
Oncol Rep; 2009 Feb; 21(2):515-21. PubMed ID: 19148530
[TBL] [Abstract][Full Text] [Related]
24. Valproic acid, a histone deacetylase inhibitor, is an antagonist for oncolytic adenoviral gene therapy.
Höti N; Chowdhury W; Hsieh JT; Sachs MD; Lupold SE; Rodriguez R
Mol Ther; 2006 Dec; 14(6):768-78. PubMed ID: 16990052
[TBL] [Abstract][Full Text] [Related]
25. Modulation of adhesion and growth of colon and pancreatic cancer cells by the histone deacetylase inhibitor valproic acid.
Jones J; Bentas W; Blaheta RA; Makarevic J; Hudak L; Wedel S; Probst M; Jonas D; Juengel E
Int J Mol Med; 2008 Sep; 22(3):293-9. PubMed ID: 18698487
[TBL] [Abstract][Full Text] [Related]
26. The effects of the histone deacetylase inhibitor valproic acid on cell cycle, growth suppression and apoptosis in multiple myeloma.
Kaiser M; Zavrski I; Sterz J; Jakob C; Fleissner C; Kloetzel PM; Sezer O; Heider U
Haematologica; 2006 Feb; 91(2):248-51. PubMed ID: 16461312
[TBL] [Abstract][Full Text] [Related]
27. Enhancement of hypoxia-induced apoptosis of human breast cancer cells via STAT5b by momilactone B.
Joung YH; Lim EJ; Kim MS; Lim SD; Yoon SY; Lim YC; Yoo YB; Ye SK; Park T; Chung IM; Bae KY; Yang YM
Int J Oncol; 2008 Sep; 33(3):477-84. PubMed ID: 18695876
[TBL] [Abstract][Full Text] [Related]
28. [Inhibitory effect of valproic acid on cell cycle of Kasumi-1 cell line and its mechanism].
Zhao L; Zhang ZH; Zhu CM
Zhonghua Xue Ye Xue Za Zhi; 2008 Dec; 29(12):802-5. PubMed ID: 19176032
[TBL] [Abstract][Full Text] [Related]
29. Mitochondria-mediated apoptosis in human breast carcinoma MCF-7 cells induced by a novel selenadiazole derivative.
Chen T; Zheng W; Wong YS; Yang F
Biomed Pharmacother; 2008 Feb; 62(2):77-84. PubMed ID: 18222058
[TBL] [Abstract][Full Text] [Related]
30. Carboxyamido-triazole inhibits proliferation of human breast cancer cells via G(2)/M cell cycle arrest and apoptosis.
Guo L; Li ZS; Wang HL; Ye CY; Zhang DC
Eur J Pharmacol; 2006 May; 538(1-3):15-22. PubMed ID: 16696967
[TBL] [Abstract][Full Text] [Related]
31. Chronic administration of valproic acid inhibits PC3 cell growth by suppressing tumor angiogenesis in vivo.
Gao D; Xia Q; Lv J; Zhang H
Int J Urol; 2007 Sep; 14(9):838-45. PubMed ID: 17760752
[TBL] [Abstract][Full Text] [Related]
32. The pan-DAC inhibitor LBH589 is a multi-functional agent in breast cancer cells: cytotoxic drug and inducer of sodium-iodide symporter (NIS).
Fortunati N; Catalano MG; Marano F; Mugoni V; Pugliese M; Bosco O; Mainini F; Boccuzzi G
Breast Cancer Res Treat; 2010 Dec; 124(3):667-75. PubMed ID: 20213084
[TBL] [Abstract][Full Text] [Related]
33. Anti-leukemic activity of valproic acid and imatinib mesylate on human Ph+ ALL and CML cells in vitro.
Kircher B; Schumacher P; Petzer A; Hoflehner E; Haun M; Wolf AM; Nachbaur D; Gastl G
Eur J Haematol; 2009 Jul; 83(1):48-56. PubMed ID: 19226363
[TBL] [Abstract][Full Text] [Related]
34. Valproic acid inhibits the growth of cervical cancer both in vitro and in vivo.
Sami S; Höti N; Xu HM; Shen Z; Huang X
J Biochem; 2008 Sep; 144(3):357-62. PubMed ID: 18515856
[TBL] [Abstract][Full Text] [Related]
35. Enhancing cisplatin sensitivity in MCF-7 human breast cancer cells by down-regulation of Bcl-2 and cyclin D1.
Yde CW; Issinger OG
Int J Oncol; 2006 Dec; 29(6):1397-404. PubMed ID: 17088977
[TBL] [Abstract][Full Text] [Related]
36. Valproic acid-mediated neuroprotection in intracerebral hemorrhage via histone deacetylase inhibition and transcriptional activation.
Sinn DI; Kim SJ; Chu K; Jung KH; Lee ST; Song EC; Kim JM; Park DK; Kun Lee S; Kim M; Roh JK
Neurobiol Dis; 2007 May; 26(2):464-72. PubMed ID: 17398106
[TBL] [Abstract][Full Text] [Related]
37. Histone deacetylase inhibitor induced modulation of anti-estrogen therapy.
Thomas S; Munster PN
Cancer Lett; 2009 Aug; 280(2):184-91. PubMed ID: 19185986
[TBL] [Abstract][Full Text] [Related]
38. Hydroxychloroquine, chloroquine, and all-trans retinoic acid regulate growth, survival, and histone acetylation in breast cancer cells.
Rahim R; Strobl JS
Anticancer Drugs; 2009 Sep; 20(8):736-45. PubMed ID: 19584707
[TBL] [Abstract][Full Text] [Related]
39. HDAC inhibitors induce apoptosis in glucocorticoid-resistant acute lymphatic leukemia cells despite a switch from the extrinsic to the intrinsic death pathway.
Tsapis M; Lieb M; Manzo F; Shankaranarayanan P; Herbrecht R; Lutz P; Gronemeyer H
Int J Biochem Cell Biol; 2007; 39(7-8):1500-9. PubMed ID: 17499001
[TBL] [Abstract][Full Text] [Related]
40. Involvement of reactive oxygen species/c-Jun NH(2)-terminal kinase pathway in kotomolide A induces apoptosis in human breast cancer cells.
Kuo PL; Chen CY; Tzeng TF; Lin CC; Hsu YL
Toxicol Appl Pharmacol; 2008 Jun; 229(2):215-26. PubMed ID: 18374381
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
